Biblio

Found 167 results
Author [ Keyword(Desc)] Title Type Year
Filters: Author is Sergio Pecorelli  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
80 and over Alopecia/chemically induced Antineoplastic Combined Chemotherapy Protocols/adverse effects/*therapeutic use Cisplatin/administration & dosage/adverse effects Combined Modality Therapy Cross-Over Studies Cyclophosphamide/administration & dosag
M. J. Piccart, Bertelsen, K., James, K., Cassidy, J., Mangioni, C., Simonsen, E., Stuart, G. C. E., Kaye, S. B., Vergote, I. B., Blom, R., Grimshaw, R., Atkinson, R. J., Swenerton, K. D., Tropé, C. G., Nardi, M., Kaern, J., Tumolo, S., Timmers, P., Roy, J. - A., Lhoas, F., Lindvall, B., Bacon, M., Birt, A., Andersen, J. E., Zee, B., Paul, J., Baron, B., and Pecorelli, S., Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results, J Natl Cancer Inst, vol. 92, pp. 699-708, 2000.
Adjuvant Cisplatin/administration & dosage Confidence Intervals Disease-Free Survival Europe Female Humans International Cooperation Middle Aged Neoplasm Staging Observation Odds Ratio Ovarian Neoplasms/*drug therapy/*pathology/surgery Prognosis Risk Fac
J. B. Trimbos, Vergote, I. B., Bolis, G., Vermorken, J. B., Mangioni, C., Madronal, C., Franchi, M., Tateo, S., Zanetta, G., Scarfone, G., Giurgea, L., Timmers, P., Coens, C., Pecorelli, S., Collaborators, E. O. R. T. C. - A. C. T. I. O. N., Research, E. Organisati, and Neoplasm, Tof Cancer-, Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial, J Natl Cancer Inst, vol. 95, pp. 113-25, 2003.
Adjuvant Cisplatin/administration & dosage Disease-Free Survival Drug Administration Schedule Female Humans International Cooperation Middle Aged Neoplasm Staging Odds Ratio Ovarian Neoplasms/*drug therapy/pathology/surgery Risk Factors Survival Analysis
J. B. Trimbos, Parmar, M. K. B., Vergote, I. B., Guthrie, D., Bolis, G., Colombo, N., Vermorken, J. B., Torri, V., Mangioni, C., Pecorelli, S., Lissoni, A., Swart, A. Marie, Neoplasm, I. Collaborat, Research, E. Organisati, and Neoplasm, Tof Cancer, International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma, J Natl Cancer Inst, vol. 95, pp. 105-12, 2003.
Adjuvant Cisplatin/therapeutic use Cyclophosphamide/therapeutic use Female Follow-Up Studies Humans Middle Aged Multivariate Analysis Ovarian Neoplasms/drug therapy/mortality/*surgery Ovariectomy/*methods Prognosis Survival Analysis
M. E. L. van der Burg, van Lent, M., Buyse, M., Kobierska, A., Colombo, N., Favalli, G., Lacave, A. J., Nardi, M., Renard, J., and Pecorelli, S., The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer, N Engl J Med, vol. 332, pp. 629-34, 1995.
Adult
S. Pecorelli, Ray-Coquard, I., Tredan, O., Colombo, N., Parma, G., Tisi, G., Katsaros, D., Lhommé, C., Lissoni, A., Vermorken, J. B., du Bois, A., Poveda, A. M., Frigerio, L., Barbieri, P., Carminati, P., Brienza, S., and Guastalla, J. P., Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes., Ann Oncol, vol. 21, no. 4, pp. 759-65, 2010.
I. B. Vergote, Tropé, C. G., Amant, F., Kristensen, G. B., Ehlen, T., Johnson, N., Verheijen, R. H. M., van der Burg, M. E. L., Lacave, A. J., Panici, P. Benedetti, Kenter, G. G., Casado, A., Mendiola, C., Coens, C., Verleye, L., Stuart, G. C. E., Pecorelli, S., and Reed, N. Simon, Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer., N Engl J Med, vol. 363, no. 10, pp. 943-53, 2010.
N. Simon Reed, Mangioni, C., Malmström, H., Scarfone, G., Poveda, A. M., Pecorelli, S., Tateo, S., Franchi, M., Jobsen, J. J., Coens, C., Teodorovic, I., Vergote, I. B., and Vermorken, J. B., Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)., Eur J Cancer, vol. 44, no. 6, pp. 808-18, 2008.
M. J. Piccart, Bertelsen, K., James, K., Cassidy, J., Mangioni, C., Simonsen, E., Stuart, G. C. E., Kaye, S. B., Vergote, I. B., Blom, R., Grimshaw, R., Atkinson, R. J., Swenerton, K. D., Tropé, C. G., Nardi, M., Kaern, J., Tumolo, S., Timmers, P., Roy, J. - A., Lhoas, F., Lindvall, B., Bacon, M., Birt, A., Andersen, J. E., Zee, B., Paul, J., Baron, B., and Pecorelli, S., Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results., J Natl Cancer Inst, vol. 92, no. 9, pp. 699-708, 2000.
B. Trimbos, Timmers, P., Pecorelli, S., Coens, C., Ven, K., van der Burg, M. E. L., and Casado, A., Surgical staging and treatment of early ovarian cancer: long-term analysis from a randomized trial., J Natl Cancer Inst, vol. 102, no. 13, pp. 982-7, 2010.
Aged
I. B. Vergote, Tropé, C. G., Amant, F., Kristensen, G. B., Ehlen, T., Johnson, N., Verheijen, R. H. M., van der Burg, M. E. L., Lacave, A. J., Panici, P. Benedetti, Kenter, G. G., Casado, A., Mendiola, C., Coens, C., Verleye, L., Stuart, G. C. E., Pecorelli, S., and Reed, N. Simon, Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer., N Engl J Med, vol. 363, no. 10, pp. 943-53, 2010.
N. Simon Reed, Mangioni, C., Malmström, H., Scarfone, G., Poveda, A. M., Pecorelli, S., Tateo, S., Franchi, M., Jobsen, J. J., Coens, C., Teodorovic, I., Vergote, I. B., and Vermorken, J. B., Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)., Eur J Cancer, vol. 44, no. 6, pp. 808-18, 2008.
M. J. Piccart, Bertelsen, K., James, K., Cassidy, J., Mangioni, C., Simonsen, E., Stuart, G. C. E., Kaye, S. B., Vergote, I. B., Blom, R., Grimshaw, R., Atkinson, R. J., Swenerton, K. D., Tropé, C. G., Nardi, M., Kaern, J., Tumolo, S., Timmers, P., Roy, J. - A., Lhoas, F., Lindvall, B., Bacon, M., Birt, A., Andersen, J. E., Zee, B., Paul, J., Baron, B., and Pecorelli, S., Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results., J Natl Cancer Inst, vol. 92, no. 9, pp. 699-708, 2000.
B. Trimbos, Timmers, P., Pecorelli, S., Coens, C., Ven, K., van der Burg, M. E. L., and Casado, A., Surgical staging and treatment of early ovarian cancer: long-term analysis from a randomized trial., J Natl Cancer Inst, vol. 102, no. 13, pp. 982-7, 2010.

Pages